Woodward Diversified Capital, LLC Global Blood Therapeutics, Inc. Transaction History

Woodward Diversified Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$25.48 - $37.34 $303,976 - $445,466	-11,930 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$32.46 - $43.42 $80,728 - $107,985	-2,487 Reduced 17.25%	11,930 $418,000
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $561,397 - $733,104	14,417 New	14,417 $587,000
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $794,648 - $1.04 Million	-20,407 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $768,323 - $1.3 Million	20,407 New	20,407 $884,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Woodward Diversified Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Woodward Diversified Capital, LLC with notifications on news.